NovaBridge Biosciences (NBP) Deferred Taxes (2020)
NovaBridge Biosciences (NBP) posted quarterly Deferred Taxes of -$19465.2 for Q4 2020, down 10.43% quarter-over-quarter from -$17626.4 in Q3 2020.
Powered by 
Analysis
NovaBridge Biosciences (NBP) Deferred Taxes (2020) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Deferred Taxes for 1 consecutive years, with -$19465.2 the latest figure, recorded in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.80 Bn | 130.95 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.54 Bn | 77.55 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.07 Bn | 52.93 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.01 Bn | 44.01 Bn | - | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.88 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.40 Bn | 32.09 Bn | 992.69 Mn | 2.66 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | - |
| 10 | NovaBridge Biosciences | 199.88 Mn | 199.88 Mn | - | - |